Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26518728 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL26518750 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL26518741 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL26518736 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL8736800 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL26518731 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL9056245 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL11567393 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL26518755 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 | |
| SCHEMBL26518724 | 0.98 | ALDH1A1 (0.36) | CA1CA2CA9ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320994-A1 | FUNCTIONAL IONIZABLE PHOSPHOLIPIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2023-10-12 | — | — | US | disclosed |
| US-20230320994-A1 | FUNCTIONAL IONIZABLE PHOSPHOLIPIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2023-10-12 | — | — | US | disclosed |
| US-5723558-A | MONOMERS OR MEDICAL MATERIAL, BIOSENSORS AND COSMETICS | NOF CORPORATION (JP) | 1998-03-03 | — | — | US | disclosed |
| EP-0790252-A1 | FUMARIC ACID DERIVATIVE AND POLYMER THEREOF | NOF CORPORATION (JP) | 1997-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320994-A1 | FUNCTIONAL IONIZABLE PHOSPHOLIPIDS | PHOSPHO1, PLA2G2C, PLTP | CA1 2099/4885CA2 1745/4885CA9 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.